G.Barekat Pharm (XTEH:BRKT1) Market Cap : IRR0 Mil (As of Apr. 29, 2024)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). G.Barekat Pharm's share price for the quarter that ended in Mar. 2017 was IRR1209.46. G.Barekat Pharm's Shares Outstanding (EOP) for the quarter that ended in Mar. 2017 was 5,459 Mil. Therefore, G.Barekat Pharm's market cap for the quarter that ended in Mar. 2017 was IRR6,602,817 Mil.

G.Barekat Pharm's quarterly market cap stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR6,602,817 Mil).

G.Barekat Pharm's annual market cap stayed the same from . 20 (IRR0 Mil) to Mar. 2016 (IRR0 Mil) but then increased from Mar. 2016 (IRR0 Mil) to Mar. 2017 (IRR6,602,817 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. G.Barekat Pharm's Enterprise Value for Today is IRR0 Mil.

G.Barekat Pharm Market Cap Historical Data

The historical data trend for G.Barekat Pharm's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Market Cap Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Market Cap

6,602,817.07

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Market Cap	-	6,602,817.07

Competitive Comparison of G.Barekat Pharm's Market Cap

For the Biotechnology subindustry, G.Barekat Pharm's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Market Cap distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Market Cap falls into.

G.Barekat Pharm Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

G.Barekat Pharm's Market Cap for the fiscal year that ended in Mar. 2017 is calculated as

Market Cap (A: Mar. 2017 )	=	Share Price (A: Mar. 2017 )	*	Shares Outstanding (EOP) (A: Mar. 2017 )
	=	IRR1209.46	*	5459.31
	=	IRR6,602,817

G.Barekat Pharm's Market Cap for the quarter that ended in Mar. 2017 is calculated as

Market Cap (Q: Mar. 2017 )	=	Share Price (Q: Mar. 2017 )	*	Shares Outstanding (EOP) (Q: Mar. 2017 )
	=	IRR1209.46	*	5459.31
	=	IRR6,602,817

G.Barekat Pharm (XTEH:BRKT1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

G.Barekat Pharm Market Cap Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines